Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Novartis
Accenture
Dow
Moodys
UBS
Colorcon
Fuji
QuintilesIMS
Queensland Health

Generated: October 23, 2017

DrugPatentWatch Database Preview

PERTZYE Drug Profile

« Back to Dashboard

What is the patent landscape for Pertzye, and what generic Pertzye alternatives are available?

Pertzye is a drug marketed by Digestive Care Inc and is included in one NDA.

The generic ingredient in PERTZYE is pancrelipase (amylase;lipase;protease). There are six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pancrelipase (amylase;lipase;protease) profile page.

Summary for Tradename: PERTZYE

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list2
Drug Prices:see details
DailyMed Link:PERTZYE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Digestive Care Inc
PERTZYE
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL022175-001May 17, 2012RXYesNo► Subscribe► Subscribe► Subscribe
Digestive Care Inc
PERTZYE
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL022175-004Jul 13, 2017RXYesNo► Subscribe► Subscribe► Subscribe
Digestive Care Inc
PERTZYE
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL022175-002May 17, 2012RXYesYes► Subscribe► Subscribe► Subscribe
Digestive Care Inc
PERTZYE
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL022175-003Oct 6, 2016RXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Citi
Healthtrust
Chubb
US Department of Justice
Dow
Queensland Health
Fuji
Daiichi Sankyo
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot